BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 17308078)

  • 1. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function.
    Brueckner B; Stresemann C; Kuner R; Mund C; Musch T; Meister M; Sültmann H; Lyko F
    Cancer Res; 2007 Feb; 67(4):1419-23. PubMed ID: 17308078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis.
    Lu L; Katsaros D; de la Longrais IA; Sochirca O; Yu H
    Cancer Res; 2007 Nov; 67(21):10117-22. PubMed ID: 17974952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Let-7a microRNA suppresses therapeutics-induced cancer cell death by targeting caspase-3.
    Tsang WP; Kwok TT
    Apoptosis; 2008 Oct; 13(10):1215-22. PubMed ID: 18758960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variations of microRNAs in human cancer: alterations in predicted secondary structure do not affect processing.
    Diederichs S; Haber DA
    Cancer Res; 2006 Jun; 66(12):6097-104. PubMed ID: 16778182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human let-7a miRNA blocks protein production on actively translating polyribosomes.
    Nottrott S; Simard MJ; Richter JD
    Nat Struct Mol Biol; 2006 Dec; 13(12):1108-14. PubMed ID: 17128272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant expression of let-7a miRNA in the blood of non-small cell lung cancer patients.
    Jeong HC; Kim EK; Lee JH; Lee JM; Yoo HN; Kim JK
    Mol Med Rep; 2011; 4(2):383-7. PubMed ID: 21468581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
    Müller DW; Bosserhoff AK
    Oncogene; 2008 Nov; 27(52):6698-706. PubMed ID: 18679415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let-7a regulation of insulin-like growth factors in breast cancer.
    Lu L; Katsaros D; Zhu Y; Hoffman A; Luca S; Marion CE; Mu L; Risch H; Yu H
    Breast Cancer Res Treat; 2011 Apr; 126(3):687-94. PubMed ID: 20848182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy?
    Tong AW; Nemunaitis J
    Cancer Gene Ther; 2008 Jun; 15(6):341-55. PubMed ID: 18369380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. let-7 microRNAs in development, stem cells and cancer.
    Büssing I; Slack FJ; Grosshans H
    Trends Mol Med; 2008 Sep; 14(9):400-9. PubMed ID: 18674967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling of microRNAs in cancer cells: technical considerations.
    Sioud M; Cekaite L
    Methods Mol Biol; 2008; 439():179-90. PubMed ID: 18370103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced epigenetic alterations after low and high LET irradiations.
    Aypar U; Morgan WF; Baulch JE
    Mutat Res; 2011 Feb; 707(1-2):24-33. PubMed ID: 21159317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Slowing down the Ras lane: miRNAs as tumor suppressors?
    Morris JP; McManus MT
    Sci STKE; 2005 Aug; 2005(297):pe41. PubMed ID: 16107327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer.
    Wang M; Hu Y; Amatangelo MD; Stearns ME
    Mol Cancer Res; 2011 Jan; 9(1):36-50. PubMed ID: 21148031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family.
    Motoyama K; Inoue H; Nakamura Y; Uetake H; Sugihara K; Mori M
    Clin Cancer Res; 2008 Apr; 14(8):2334-40. PubMed ID: 18413822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide profiling of chromatin signatures reveals epigenetic regulation of MicroRNA genes in colorectal cancer.
    Suzuki H; Takatsuka S; Akashi H; Yamamoto E; Nojima M; Maruyama R; Kai M; Yamano HO; Sasaki Y; Tokino T; Shinomura Y; Imai K; Toyota M
    Cancer Res; 2011 Sep; 71(17):5646-58. PubMed ID: 21734013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
    Gramantieri L; Ferracin M; Fornari F; Veronese A; Sabbioni S; Liu CG; Calin GA; Giovannini C; Ferrazzi E; Grazi GL; Croce CM; Bolondi L; Negrini M
    Cancer Res; 2007 Jul; 67(13):6092-9. PubMed ID: 17616664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.